Dandelion Joins Primary Ventures Webinar: Advancing Precision Medicine Beyond Oncology
Nick Gossen, Dandelion Health’s Head of Growth, joined this forward-looking panel discussion, hosted by Primary Venture Partners.
About the webinar:
Hosted by Sam Toole, Partner at Primary, this virtual session explored questions like:
How should we define precision medicine beyond oncology — and what’s the real opportunity for life sciences today?
Why now? What scientific, technological, or industry forces are accelerating this shift?
What are the most promising use cases — and where could multimodal data make the biggest impact?
What new challenges and trade-offs arise as precision becomes more operationalized? (e.g., trial design, label strategy, regulatory confidence)
This event was invite-only, but we're excited to give you exclusive access to the panel session here.
Exclusive Access: Watch the Webinar
Expert Panel Participants
Nick Gossen, Head of Growth at Dandelion Health
Adam Platt, PhD, VP & Head of Respiratory & Immunology Translational Sciences at AstraZeneca
David Ouyang, MD, Cardiologist & Research Scientist at The Permanente Medical Group; Assistant Professor at Cedars-Sinai
Moderated by Sam Toole, Partner at Primary Ventures
